The Liver Meeting 2014: Summary of Presentations on Genotype 3 HCV Infection from the 65th Annual Liver Meeting of the American Association for the Study of Liver Diseases (AASLD), Held in Boston, MA, USA, on 7th-11th November, 2014
After genotype 1 (GT1), genotype 3 (GT3) is the second most common hepatitis C virus (HCV) genotype worldwide, with an estimated worldwide prevalence of 54.3 million. As its high prevalence already represents a significant burden, this genotype appears to be one of the most difficult to treat using...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Medical Journal
2015-01-01
|
| Series: | European Medical Journal Hepatology |
| Online Access: | http://emjreviews.com/wp-content/uploads/The-Liver-Meeting-2014-Summary-of-Presentations-on-Genotype-3-HCV-Infection-from-the-65th-Annual-Liver-Meeting-of-the-American-Association-for-the-Study.pdf |